Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

Is DaVita Stock Underperforming the Nasdaq?

Valued at a market cap of $9.4 billion, DaVita Inc. (DVA) provides kidney dialysis services for patients suffering from chronic kidney failure. The Denver, Colorado-based company also offers outpatient, hospital inpatient, and home-based hemodialysis services, as well as clinical laboratory services.

Companies worth $2 billion or more are typically classified as “mid-cap stocks,” and DaVita fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the medical care facilities industry. The company’s strength lies in its extensive network of dialysis centers across the U.S., which allows it to serve a large and growing population of patients with chronic kidney disease. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.